| Issue Date | Title | Author(s) |
| 17-Feb-2024 | Alterations in Genome Organization in Lymphoma Cell Nuclei due to the Presence of the t(14;18) Translocation | Garimberti, E; Federico, C; Ragusa, D; Bruno, F; Saccone, S; Bridger, JM; Tosi, S |
| 22-Nov-2021 | Chromosomal Rearrangements and Altered Nuclear Organization: Recent Mechanistic Models in Cancer | Federico, C; Bruno, F; Ragusa, D; Clements, CS; Brancato, D; Henry, MP; Bridger, JM; Tosi, S; Saccone, S |
| 23-Nov-2023 | Contribution of histone variants to aneuploidy: a cancer perspective | Ragusa, D; Vagnarelli, P |
| 25-Apr-2019 | Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders | Federico, C; Owoka, T; Ragusa, D; Sturiale, V; Caponnetto, D; Leotta, CG; Bruno, F; Foster, HA; Rigamonti, S; Giudici, G; Cazzaniga, G; Bridger, JM; Sisu, C; Saccone, S; Tosi, M |
| 7-Oct-2022 | Dissecting infant leukemia developmental origins with a hemogenic gastruloid model | Ragusa, D; Suen, C-W; Torregrosa Cortes, G; Dijkhuis, L; Byrne, C; Ionescu, G-A; Cerveira, J; Kranc, KR; Bigas, A; Garcia-Ojalvo, J; Martinez Arias, A; Pina, C |
| 3-Sep-2022 | Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profiles | Ragusa, D; Cicirò, Y; Federico, C; Saccone, S; Bruno, F; Saeedi, R; Sisu, C; Pina, C; Sala, A; Tosi, S |
| 23-Feb-2024 | Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies | Cicirò, Y; Ragusa, D; Sala, A |
| 2017 | Folate deficiency as predisposing factor for childhood leukaemia: A review of the literature | Cantarella, CD; Ragusa, D; Giammanco, M; Tosi, S |
| 26-Feb-2021 | From FISH to Hi-C: the chromatin architecture of the chromosomal region 7q36.3, frequently rearranged in leukemic cells, is evolutionary conserved | Gulino, GM; Bruno, F; Sturiale, V; Brancato, D; Ragusa, D; Tosi, S; Saccone, S; Federico, C |
| 27-Dec-2023 | Haematopoietic development and HSC formation in vitro: promise and limitations of gastruloid models | Dijkhuis, L; Johns, A; Ragusa, D; van den Brink, S; Pina, C |
| 15-Nov-2022 | Haemogenic Gastruloids Recapitulate Developmental Haematopoiesis and Provide an Ontogeny-Relevant Context to Dissect the Origins of Infant Leukemia | Ragusa, D; Suen, C-W; Torregrosa, G; Dijkhuis, L; Byrne, C; Balayo, T; Tavosanis, A; Durko, J; Place, K; Domingues, AF; Kranc, K; Garcia-Ojalvo, J; Martinez Arias, A; Pina, C |
| - | Insights into maternal diet for the prevention of childhood leukaemia | Cantarella, CD; Ragusa, D; Tosi, M |
| 7-Jun-2023 | MAT2A inhibition in AML unveils therapeutic potential of combining DNA demethylating agents with UPR targeting | Zeka, K; Taylor, AV; Samarista, R; Ragusa, D; Suen, C-W; Cyran, OC; Domingues, AF; Meduri, E; Huntly, BJP; Forte, D; Curti, A; Pina, C |
| 30-Jan-2023 | Mechanisms associated with t(7;12) acute myeloid leukaemia: from genetics to potential treatment targets | Ragusa, D; Dijkhuis, L; Pina, C; Tosi, S |
| 19-Dec-2023 | The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma | Cicirò, Y; Ragusa, D; Nevado, PT; Lattanzio, R; Sala, G; Des Rochers, T; Millard, M; Andersson, M; Stenman, G; Sala, A |
| 29-Oct-2019 | MLL-rearranged acute leukemia with t(4;11)(q21;q23) - current treatment options. Is there a role for CAR-T cell therapy? | Britten, O; Ragusa, D; Tosi, S; Kamel, YM |
| 11-Nov-2022 | Pan-Cancer Analysis Identifies MNX1 and Associated Antisense Transcripts as Biomarkers for Cancer | Ragusa, D; Tosi, S; Sisu, C |
| 2019 | The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): revised characterisation of cytogenetic features | Ragusa, D; Makarov, E; Britten, O; Moralli, D; Green, C; Tosi, M |
